GALDY — Galderma Group AG/ADR

OTC · Unknown · Unknown · CIK 2021390 ·
Last close
$43.89
Market Cap
$51.17B
52W High
$46.31
52W Low
$38.69
ADV30
90,586
Next earnings
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 13,393,000,000 780,000,000 5,244,000,000
Jun 2025 12,877,000,000 458,000,000 5,147,000,000
Dec 2024 12,617,000,000 457,000,000 4,827,000,000

Balance + Analyst (yfinance extras)

Retained Earnings
$6,347,000,000
Inventory
$525,000,000
Receivables
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,922,999,808
EBITDA
$1,386,000,000
Free Cash Flow
$874,625,024
Enterprise Value
$53,096,951,808
Total Cash
$839,000,000
Total Debt
$2,716,000,000
Shares Out
1,165,944,685
Trailing EPS
$0.74
Book Value
$7.05
ROE
10.8%
ROA
5.4%
Div Yield
0.20%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 5,241,000,000 876,000,000 613,000,000 13,393,000,000 5,244,000,000 1,185,000,000
Dec 2024 4,440,000,000 678,000,000 231,000,000 12,617,000,000 4,827,000,000 488,000,000
Dec 2023 4,117,000,000 611,000,000 -57,000,000 12,471,000,000 7,102,000,000 165,000,000
Dec 2022 3,823,900,000 406,000,000 -98,500,000 111,300,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$6.32

Peers — same industry

TickerNameMarket CapLastDaily %
CTVA Corteva, Inc. $50.57B $75.79
WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP $50.33B $297.98
NKE NIKE, Inc. $49.56B $41.23
ROK ROCKWELL AUTOMATION, INC $49.47B $445.51
GDERF Galderma Group AG/ADR $49.13B $210.70

News headlines (Yahoo Finance, 1h cache)

Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?
2026-06-16 13:40 · Yahoo
What Makes Galderma Group AG - Unsponsored ADR (GALDY) a New Strong Buy Stock
2026-05-05 16:00 · Yahoo
European Stocks That May Be Trading Below Their Estimated Value In February 2026
2026-02-17 10:38 · Yahoo
Global Market Highlights 3 Stocks That May Be Trading Below Their Estimated Value
2026-02-17 09:38 · Yahoo
European Market Highlights 3 Stocks Priced Below Estimated Value
2026-02-17 05:38 · Yahoo
3 European Stocks Estimated To Be Trading Up To 48.2% Below Intrinsic Value
2026-02-16 10:37 · Yahoo
3 European Stocks Estimated To Be Trading Up To 39.9% Below Intrinsic Value
2026-02-16 05:38 · Yahoo
3 European Stocks Possibly Trading At Discounts Of Up To 39.3%
2026-02-13 10:38 · Yahoo
3 European Stocks Estimated To Be Up To 49.8% Below Intrinsic Value
2026-02-13 05:38 · Yahoo
3 European Stocks Estimated To Be Trading At Up To 49.9% Discount
2026-01-12 10:37 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.